Dicer-2 mutations in Aedes aegypti cells lead to a diminished antiviral function against Rift Valley fever virus and Bunyamwera virus infection

Susann Dornbusch,Melinda Reuter,Rhys H. Parry,Michael Stern,Stefanie C. Becker,Esther Schnettler
DOI: https://doi.org/10.1099/jgv.0.002046
2024-11-09
Journal of General Virology
Abstract:Mosquitoes are known to transmit different arthropod-borne viruses belonging to various virus families. The exogenous small interfering RNA pathway plays an important role in the mosquito defence against such virus infections, with Dicer-2 (Dcr2) as one of the key proteins that initiates the cleavage of viral dsRNAs into 21 nt long virus-derived small interfering RNAs. Previous data identified the importance of various motifs in Dcr2 for its small interfering RNA (siRNA)-mediated antiviral activity. However, all these data focus on positive-strand RNA viruses, although negative-strand RNA viruses, like Bunyaviricetes , include several important mosquito-borne viruses. Here, we aim to investigate the importance of different domains of Dcr2 for antiviral activity against viruses of the Bunyaviricetes . For this, we used the Aedes aegypti- derived Dcr2 knock-out cell line Aag2-AF319 to study the importance of the helicase, RNase III and PIWI–Argonaute–Zwille domains of Dcr2 on the antiviral activity of two viruses belonging to different families of the Bunyaviricetes : the Rift Valley fever virus (RVFV) vaccine strain MP12 ( Phenuiviridae , Phlebovirus ) and the Bunyamwera orthobunyavirus (BUNV; Peribunyaviridae , Orthobunyavirus ). All three domains were determined to be critical for the antiviral activity against both RVFV and BUNV. Interestingly, one specific mutation in the helicase domain (KN) did not result in a loss of antiviral activity for RVFV, but for BUNV, despite losing the ability to produce 21 nt siRNAs.
biotechnology & applied microbiology,virology
What problem does this paper attempt to address?